The present invention addresses the problem of providing a novel pharmaceutical composition for urinary incontinence prevention and/or treatment, said pharmaceutical composition being different from conventional drugs. The present invention provides a urinary incontinence preventive agent and/or therapeutic agent that have, as an active ingredient, 1-[2({[trans-3-fluoro-1-(3-fluoropyridine-2-yl)cyclobutyl]methyl}amino)pyrimidine-5-yl]-1H-pyrrole-3-carboxamide or a salt thereof.
